World

Coronavirus Vaccine: “Unexpected Illness” Stops Johnson & Johnson Trial

A clinical trial of the COVID-19 vaccine by Johnson & Johnson in the United States was discontinued after participants developed a “disease of unknown cause.”

In a statement, the pharmaceutical giant said further administration in all COVID-19 candidate vaccine clinical trials was “temporarily suspended.”

This includes Phase 3 of the Janssen-Pharma trial, called the “ensemble,” with up to 60,000 volunteers on three continents.

Related: Follow Live Coronavirus Coverage

media_cameraJohnson & Johnson has suspended the COVID-19 Candidate Vaccine Trial in Phase 3. Photo: Mark Ralston / AFP

“According to our guidelines, participants’ illnesses are reviewed and evaluated by the ensemble’s independent data safety monitoring committee and in-house clinical and safety physicians,” said Johnson & Johnson.

All clinical trials state that they have pre-designated guidelines that allow them to be suspended in the event of an unexpected serious adverse event that may be associated with a vaccine or investigational drug. I will.

“Therefore, all medical information can be carefully reviewed before deciding whether to resume the study,” the company said.

“We must respect the privacy of this participant.

“We are also learning about this participant’s illness. It is important to know all the facts before sharing additional information.”

Related: Donald Trump Negative with COVID-19

Prime Minister Scott Morrison and Professor Trentmanro on a tour of the University of Queensland Vaccine Institute in Brisbane.Photo: Darren England / Poole / Getty Images
media_cameraPrime Minister Scott Morrison and Professor Trentmanro on a tour of the University of Queensland Vaccine Institute in Brisbane.Photo: Darren England / Poole / Getty Images

Johnson & Johnson signed a contract with the European Union last week to inoculate 200 million doses of the vaccine “with regulatory approval or approval” and another 200 million doses.

by New York Times’ The Coronavirus Vaccine Tracker has 11 vaccines in a large Phase 3 efficacy test worldwide, including a study by AstraZeneca and Oxford University in the United Kingdom.

Prime Minister Scott Morrison signed an “intention” regarding the supply of the vaccine if the trial was successful, and in August promised that the jab would be provided free of charge to “all Australians.”

Late trials of AstraZeneca were suspended for a week in September due to a UK study participant’s illness, but resumed after receiving a green light from safety observers.

Stop the virus vaccine originally published as “disease of unknown cause”

Coronavirus Vaccine: “Unexpected Illness” Stops Johnson & Johnson Trial

Source link Coronavirus Vaccine: “Unexpected Illness” Stops Johnson & Johnson Trial

Back to top button